Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Watch more discussion from the panel below. On Friday, the panel will consider boosters for Johnson & Johnson...

  • Fabulous. @US_FDA sez yes to Moderna Booster. If your Doc thinks you should get a booster, schedule it ASAP. Truth is, you don’t know if you have enough antibodies to prevent you from getting sick or giving #Covid to someone else. #MAXXVAXX https://t.co/mtkmzmE4VQ - view on twitter

Mashup Score:7

NCQA Blog

NCQA shares COVID-19 stories, ideas and tips from primary care practices who coordinate care for their patients and solicits other insights from the...

BE ON THE LOOKOUT FOR SCAMS! Please be aware that there are illegitimate companies who may reach out to you regarding registration and hotel...

The COVID-19 pandemic has caused significant impacts on PwCF and on healthcare professionals who provide specialized CF care and clinical...

The global pandemic of the novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has presented...

News about COVID-19 including shortages, pandemic modeling, viability and susceptibility. Learn how physicians are...

It’s a myth that proliferates even in one of the world’s most vaccinated countries, despite health experts consistently denying its...

Mashup Score:1

KIRO 7 News Seattle

Merck COVID drug studied at Fred Hutch - 21 hours

Mashup Score:1

Merck released the clinical trial results of its COVID-19 antiviral drug, molnupiravir. Molnupiravir is the first treatment for COVID that can be taken orally....

The recommendation applies to people 65 years and older, those 18 to 64 who are at high risk of severe COVID and those whose...

The Journal of Laryngology & Otology – Coronavirus...